This journal offers authors two choices to publish their research:
|Gold Open Access||Subscription|
|Articles are freely available to both subscribers and the wider public with permitted reuse.||Articles are made available to subscribers as well as developing countries and patient groups through our access programs.|
|An open access publication fee is payable by authors or their research funder.||No open access publication fee.|
From January 2020 Neuroimage will become an open access journal. Authors who publish in Neuroimage will be able make their work immediately, permanently, and freely accessible. Neuroimage authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright to their published work.
Neuroimage continues with the same aims and scope, editorial team, submission system and rigorous peer review.Please note: Authors who have submitted papers before the 13th of October 2019 will have their accepted paper published in Neuroimage at no charge. Authors submitting papers after this date will be requested to pay the APC. For full information on publishing your paper open access in Neuroimage, visit the journal's guide for authors, or visit our FAQs page.
In accordance with Funding Body requirements, Elsevier does offer alternative open access publishing options. Visit our open access page for full information.Your publication choice will have no effect on the peer review process or acceptance of your submission.
Details on Gold Open Access Articles:User Rights
All articles published gold open access will be immediately and permanently free for everyone to read and download. We offer authors a choice of user licenses, which define the permitted reuse of articles. We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows:
• Creative Commons Attribution (CC BY)
• Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
To provide gold open access, this journal has a publication fee which needs to be met by the authors or their research funders for each article published open access. The gold open access publication fee for this journal is USD 3250, excluding taxes.From January 2020 Neuroimage will become an open access journal. After the 13th of October 2019, this fee will be USD 3000, excluding taxes, and will be requested for all accepted papers.
Funding Body AgreementsElsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body open access policies and may also be reimbursed for their publication fees.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our open access page for further information. An author can also self-archive their author manuscript immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.An author is entitled to post the accepted manuscript in their institution's repository and make this public after an embargo period (known as green Open Access). The embargo period for this journal can be found below.
The published journal article cannot be shared publicly, for example on ResearchGate or Academia.edu, to ensure the sustainability of peer-reviewed research in journal publications.Embargo Period
For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before a manuscript becomes available for free to the public. This is called an embargo period and it begins from the date the article is formally published online in its final and fully citable form. Find out more
This journal has an embargo period of 12 months.
Journal Article Publishing Support Center